This information was published on 2026-02-24T10:35:49 for IP Right Acceptance Published.
| Field | Value |
| (210) | 2494020 |
| (220) |
28 Oct 2024
|
| (300) |
US, 30 Apr 2024, 98526710
|
| (500) |
It is a condition of registration that any use in respect of pharmaceuticals will be limited to such goods containing substances belonging to the pharmacological group designated by the International Non-Proprietary Name stem -TIDE.
|
| (511) (510) |
Class 5
Pharmaceutical preparations for the treatment of diabetes, endocrine diseases and disorders, metabolic diseases and disorders, and obesity; Pharmaceutical preparations for weight reduction and long-term weight loss maintenance. |
| (540) | MARITIDE |
| (550) | Word |
| (730) |
Amgen Inc.
|
| (750) |
Spruson & Ferguson
|
Find out more about publications on the About page.